At Darya Investment Inc., we are committed to advancing innovation by investing in the backbone of the life sciences industry—Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs). These critical partners enable pharmaceutical, biotechnology, and health product companies to accelerate discovery, streamline development, and scale production with precision and efficiency.

Our mission is to support the growth of service-based organizations that drive scientific progress and commercial readiness. We invest in companies that offer cutting-edge expertise, high-quality infrastructure, and flexible, scalable solutions across the drug development and manufacturing lifecycle.

Darya Investment Inc. partners with CROs and CMOs that specialize in:

• Preclinical and clinical research services

• Analytical and regulatory support

• Formulation development and process optimization

• GMP manufacturing and supply chain services

We go beyond capital—offering strategic insight, operational guidance, and access to a global network of collaborators and clients. Our goal is to accelerate the success of high-performing service providers that are essential to bringing safe, effective, and innovative products to market.

Darya Investment Inc. is where scientific rigor meets business scale. Together with our partners, we build stronger foundations for innovation—delivering value to both the industry and the patients it serves.

Let’s power the future of life sciences—smarter, faster, together.